Jodi Doyle

Background

About Jodi Doyle

Top-producing sales hunter who consistently surpassed sales goals (up to 600%) throughout pharmaceutical career. Expertise launching new products and expanding revenue in B2B, pharmaceutical and specialty biotechnology arenas. Strong, expanding clinical knowledge of multiple disease states. Work effectively both independently and in strategic collaboration with deep physician network throughout oncology and urology. Experienced in multiple channels of drug distribution, Oncology/Urology GPOs, hospitals (including 340B hospitals), wholesalers and specialty pharmacies. Expertise in Buy and Bill, In-Servicing and Managed Care Landscape. Known for strong customer loyalty in competitive markets. Highlights of Sales and Market Leadership Awards 2023 surpassed Eligard goal by 115% Semester 2 2023 Principles Club Award Recognition #4 in Nation for Jatenzo Annual TRx Growth 221% 2023 #1 in Nation Leading Eligard share in Oncology 2023 Winner Eligard Banana Split Contest.#1 in Region. Awarded incentive dollars 2023-2022 Selected to represent Tolmar at AUA Annual Meetings 2022 Chosen for Eligard ELIte Team 2022 Exceeded Fensolvi Goal by 600% in division’s final quarter promoting product 2021 Won Fensolvi New Writer Contest. Awarded Tier 2 incentive dollars 2020 Launched Rare Disease Injectable for CPP. Won Fensolvi Fast Start Contest. Awarded Tier 3 incentive dollars 2020 Principles Club Recognition for Absolute Volume Increase, Percent Volume Increase and Market Share Increase for Eligard. Ranked #4 in Nation. Surpassed goal by 269% Awarded incentive trip 2005-2004 Back-to-back Ruby Winners Circle Awards GSK